Dr. Rene Jackstadt

Dr. Rene‑Filip Jackstadt is a clinician‑scientist and junior group leader at the German Cancer Research Center (DKFZ) and HI‑STEM in Heidelberg. He heads the “Cancer Progression and Metastasis” lab, where he leverages next‑generation colorectal cancer models—such as genetically engineered mice, patient‑derived organoids, and multi‑omics profiling—to unravel cellular programs that drive metastasis and therapy resistance, translating key …

Prof. Dr. Laura Hinze

Dr. Laura Hinze is a German physician-scientist and a leading young cancer researcher based at Hannover Medical School (MHH). Born in 1997 in Minden, she began her medical degree at the age of 16 and completed her MD thesis in 2020 under Martin Stanulla at MHH, focusing on pediatric hematology-oncology. Her research centers on understanding molecular mechanisms …

Prof. Dr. Matthias Ebert

Prof. Dr. med. Matthias Ebert is a distinguished clinician-scientist and academic leader in the field of gastroenterology, with a particular emphasis on gastrointestinal oncology and translational medicine. Since 2011, he has served as Director of the II. Medical Clinic (Department of Gastroenterology, Hepatology, Infectious Diseases, and Nutritional Medicine) at the University Medical Center Mannheim, affiliated …

Prof. Dr. Elke Burgermeister

Dr. Elke Burgermeister is a molecular oncologist and senior staff scientist based at Heidelberg University and the Universitätsklinikum Mannheim. She leads the Molecular Oncology Research Group within the II. Medical Clinic—specializing in gastroenterology, hepatology, infectious diseases, and nutritional medicine. Her research focuses on the molecular mechanisms underlying the development and progression of gastrointestinal cancers, especially gastric and …

Dr. Kim Boonekamp

Dr. Kim Boonekamp is a postdoctoral researcher in the Boutros Lab at the German Cancer Research Center (DKFZ) and BioQuant Heidelberg. Her work focuses on functional genomics and molecular human genetics, with a particular interest in how genetic and pharmacological perturbations shape cellular phenotypes in cancer. She works with advanced model systems such as patient-derived …

Prof. Dr. Michael Boutros

Prof. Boutros studied biochemistry and biology at RWTH Aachen, Witten/Herdecke, and conducted his PhD research at EMBL/Heidelberg under Marek Mlodzik (completed 1999). He earned an MPA from Harvard Kennedy School (2001) before continuing as a postdoctoral researcher at Harvard Medical School (1999–2003) . In 2003, he returned to Heidelberg as an Emmy‑Noether Group Leader at …

Prof. Dr. Johannes Betge

Prof. Johannes Betge is a is a physician-scientist, head of the Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models at the German Cancer Research Center (DKFZ) and attending physician in gastroenterology at University Medical Center Mannheim. Prof. Betge earned his doctoral degree at Heidelberg University and completed clinical training in internal medicine at …